BALRAM BHARGAVA
COVID-19 Vaccination in India: Focus is to Fully Vaccinate Adult Population, Booster Dose Not Pertinent at Moment, Says ICMR DG Balram Bhargava
New York Times Article on India’s COVID-19 Response ‘Provocative’, ‘Attention-Seeking’, Says ICMR Chief Balram Bhargava
COVID-19 Booster Dose Not Central Theme of Scientific and Public Health Discussions at the Moment, Says ICMR Chief Balram Bhargava
COVID-19 Vaccines ‘Disease-Modifying’ Not 'Preventing'; Masks Must Even After 2nd Dose of Vaccination, Says ICMR Director Balram Bhargava
COVID-19 Vaccine Update: Bharat Biotech's COVAXIN Offers Protection Against Beta And Delta Variants of Coronavirus, Claims Study
No COVID-19 Vaccine Shortage in India, Confident of Vaccinating Entire Population by December 2021, Says ICMR Chief
Post Vaccination Breakthrough Infection in India: 2 to 4 per 10,000 People Infected With COVID-19 After Receiving Jabs of Coronavirus Vaccination; Check Detailed Data
New COVID Strains Symptoms: How Kent Variant Is Different From the Original One? Here's What You Should Know
COVID-19 in India: Four Coronavirus Cases With South Africa Strain And With Brazil Variant Detected
Google Trends